High Minor Cannabinoid Lines

High Minor Cannabinoid Lines refer to cannabis breeding projects selectively developed to express elevated levels of compounds beyond THC and CBD, such as CBG, CBC, CBN, or THCV. These lines emerged from increased interest in the full cannabinoid spectrum and represent a departure from THC-maximization breeding strategies. Lineage records frequently report that breeders working in this category often cross chemovars known to accumulate specific minor cannabinoids, then stabilize expression across generations. High minor cannabinoid lines typically require careful phenotype selection, as expression of these compounds can be genetically unstable or dependent on cultivation conditions. These genetics remain largely experimental in commercial breeding, with most lines still in development or limited availability. Understanding their cannabinoid profiles requires third-party testing, as pheno

Breeders use high minor cannabinoid lines to expand product differentiation and explore cannabinoid synergy effects in consumer and research markets. Stabilizing minor cannabinoid expression requires multi-generational selection and often involves backcrossing to preserve rare alleles while maintaining plant vigor.